UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dolutegravir based antiretroviral therapy compared to other combined antiretroviral regimens for the treatment of HIV-infected naive patients: A systematic review and meta-analysis

PloS one, 2019-09, Vol.14 (9), p.e0222229-e0222229

2019

Volltextzugriff (PDF)

Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo

Nature (London), 2020-08, Vol.584 (7821), p.425-429

2020

Volltextzugriff (PDF)

Hepatitis C virus viral load distribution in the era of extended access to direct acting antivirals treatment: a real-life single center study

European journal of gastroenterology & hepatology, 2021-12, Vol.33 (1S Suppl 1), p.e1076-e1077

2021

Volltextzugriff (PDF)

COVID-19: The wrong target for healthcare liability claims

Legal medicine (Tokyo, Japan), 2020-09, Vol.46, p.101718-101718, Article 101718

2020

Volltextzugriff (PDF)

Abacavir use and cardiovascular disease events: a meta-analysis of published and unpublished data

AIDS (London), 2011-10, Vol.25 (16), p.1993-2004

2011

Volltextzugriff (PDF)

Anal and oral human papillomavirus (HPV) infection in HIV-infected subjects in northern Italy: a longitudinal cohort study among men who have sex with men

BMC infectious diseases, 2011-05, Vol.11 (1), p.150-150, Article 150

2011

Volltextzugriff (PDF)

Development and validation of a simple and robust HPLC method with UV detection for quantification of the hepatitis C virus inhibitor daclatasvir in human plasma

Journal of pharmaceutical and biomedical analysis, 2017-02, Vol.134, p.275-281

2017

Volltextzugriff (PDF)

HIV Replication at Low Copy Number and its Correlation with the HIV Reservoir: A Clinical Perspective

Current HIV research, 2015-05, Vol.13 (3), p.250-257

2015

Volltextzugriff (PDF)

Vaccine against SARS-CoV-2 in previously infected health care workers

EBioMedicine, 2021-09, Vol.71, p.103556-103556, Article 103556

Parisi, Saverio Giuseppe

2021

Volltextzugriff (PDF)

Marked decrease in acquired resistance to antiretrovirals in latest years in Italy

Clinical microbiology and infection, 2021-07, Vol.27 (7), p.1038.e1-1038.e6

2021

Volltextzugriff (PDF)

Infectious disease ward admission positively influences P. jiroveci pneumonia (PjP) outcome: A retrospective analysis of 116 HIV-positive and HIV-negative immunocompromised patients

PloS one, 2017-05, Vol.12 (5), p.e0176881-e0176881

2017

Volltextzugriff (PDF)

COVID-19: The wrong target for healthcare liability claims

Legal medicine (Tokyo, Japan), 2020-09, Vol.46, p.101718-101718

2020

Volltextzugriff (PDF)

Latent Tuberculosis Infection in Haematopoietic Stem Cell Transplant Recipients: A Retrospective Italian Cohort Study in Tor Vergata University Hospital, Rome

International journal of environmental research and public health, 2022-08, Vol.19 (17), p.10693

2022

Volltextzugriff (PDF)

Author Correction: Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo

Nature (London), 2021-02, Vol.590 (7844), p.E11-E11

2021

Volltextzugriff (PDF)

Baseline Cellular HIV DNA Load Predicts HIV DNA Decline and Residual HIV Plasma Levels during Effective Antiretroviral Therapy

Journal of Clinical Microbiology, 2012-02, Vol.50 (2), p.258-263

2012

Volltextzugriff (PDF)

Development of a simple HPLC–UV method for the determination of the hepatitis C virus inhibitor simeprevir in human plasma

Journal of pharmaceutical and biomedical analysis, 2016-03, Vol.121, p.197-203

2016

Volltextzugriff (PDF)

Soluble CD163 and soluble CD14 plasma levels but not cellular HIV-DNA decrease during successful interferon-free anti-HCV therapy in HIV-1–HCV co-infected patients on effective combined anti-HIV treatment

Medical microbiology and immunology, 2018-08, Vol.207 (3-4), p.183-194

2018

Volltextzugriff (PDF)

BNT162b2 SARS-CoV-2 Vaccination Elicits High Titers of Neutralizing Antibodies to Both B.1 and P.1 Variants in Previously Infected and Uninfected Subjects

Life (Basel, Switzerland), 2021-08, Vol.11 (9), p.896

2021

Volltextzugriff (PDF)

Comparable Post-Vaccination Decay of Neutralizing Antibody Response to Wild-Type and Delta SARS-CoV-2 Variant in Healthcare Workers Recovered from Mild or Asymptomatic Infection

Vaccines (Basel), 2022-04, Vol.10 (4), p.580

2022

Volltextzugriff (PDF)

Viral infections of the central nervous system in elderly patients: a retrospective study

International journal of infectious diseases, 2016-03, Vol.44 (C), p.8-10

2016

Volltextzugriff (PDF)

Legal scenarios in the coronavirus time: Medico legal implications in the aspects of governance

Legal medicine (Tokyo, Japan), 2021-02, Vol.48, p.101832-101832, Article 101832

2021

Volltextzugriff (PDF)

HPV Prophylactic Vaccination in Males Improves the Clearance of Semen Infection

EBioMedicine, 2015-10, Vol.2 (10), p.1487-1493

2015

Volltextzugriff (PDF)

Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV

Cochrane database of systematic reviews, 2013-06, Vol.2013 (6), p.CD008270

2013

Volltextzugriff (PDF)

Rome Consensus Conference - statement; human papilloma virus diseases in males

BMC public health, 2013-02, Vol.13 (1), p.117-117, Article 117

2013

Volltextzugriff (PDF)

Faster decay of neutralizing antibodies in never infected than previously infected healthcare workers three months after the second BNT162b2 mRNA COVID-19 vaccine dose

International journal of infectious diseases, 2021-11, Vol.112, p.40-44

2021

Volltextzugriff (PDF)

1 – 25 von 197

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(180)
Mit Volltextzugriff
(176)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Dolutegravir based antiretroviral therapy compared to other combined antiretroviral regimens for the treatment of HIV-infected naive patients: A systematic review and meta-analysis

Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo

Hepatitis C virus viral load distribution in the era of extended access to direct acting antivirals treatment: a real-life single center study

COVID-19: The wrong target for healthcare liability claims

Abacavir use and cardiovascular disease events: a meta-analysis of published and unpublished data

Anal and oral human papillomavirus (HPV) infection in HIV-infected subjects in northern Italy: a longitudinal cohort study among men who have sex with men

Development and validation of a simple and robust HPLC method with UV detection for quantification of the hepatitis C virus inhibitor daclatasvir in human plasma

HIV Replication at Low Copy Number and its Correlation with the HIV Reservoir: A Clinical Perspective

Vaccine against SARS-CoV-2 in previously infected health care workers

Marked decrease in acquired resistance to antiretrovirals in latest years in Italy

Infectious disease ward admission positively influences P. jiroveci pneumonia (PjP) outcome: A retrospective analysis of 116 HIV-positive and HIV-negative immunocompromised patients

COVID-19: The wrong target for healthcare liability claims

Latent Tuberculosis Infection in Haematopoietic Stem Cell Transplant Recipients: A Retrospective Italian Cohort Study in Tor Vergata University Hospital, Rome

Author Correction: Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo

Baseline Cellular HIV DNA Load Predicts HIV DNA Decline and Residual HIV Plasma Levels during Effective Antiretroviral Therapy

Development of a simple HPLC–UV method for the determination of the hepatitis C virus inhibitor simeprevir in human plasma

Soluble CD163 and soluble CD14 plasma levels but not cellular HIV-DNA decrease during successful interferon-free anti-HCV therapy in HIV-1–HCV co-infected patients on effective combined anti-HIV treatment

BNT162b2 SARS-CoV-2 Vaccination Elicits High Titers of Neutralizing Antibodies to Both B.1 and P.1 Variants in Previously Infected and Uninfected Subjects

Comparable Post-Vaccination Decay of Neutralizing Antibody Response to Wild-Type and Delta SARS-CoV-2 Variant in Healthcare Workers Recovered from Mild or Asymptomatic Infection

Viral infections of the central nervous system in elderly patients: a retrospective study

Legal scenarios in the coronavirus time: Medico legal implications in the aspects of governance

HPV Prophylactic Vaccination in Males Improves the Clearance of Semen Infection

Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV

Rome Consensus Conference - statement; human papilloma virus diseases in males

Faster decay of neutralizing antibodies in never infected than previously infected healthcare workers three months after the second BNT162b2 mRNA COVID-19 vaccine dose

Suchergebnisse filtern